ABT
Abbott Laboratories
Stock
$96.69−2.14 (−2.17%)Close Oct 1, 2026
| Capital expenditures (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $2.1B | −8.0% | −0.1% | 6.9% |
| Capital expenditures (TTM) | $2.1B |
|---|---|
| YoY | −8.0% |
| 5-year CAGR | −0.1% |
| 10-year CAGR | 6.9% |
Capital expenditures
| Period | Capex | YoY |
|---|---|---|
| 2025 | $2.2B | −1.6% |
| 2024 | $2.2B | +0.2% |
| 2023 | $2.2B | +23.9% |
| 2022 | $1.8B | −5.7% |
| 2021 | $1.9B | −13.4% |
| 2020 | $2.2B | +32.9% |
| 2019 | $1.6B | +17.5% |
| 2018 | $1.4B | +22.8% |
| 2017 | $1.1B | +1.2% |
| 2016 | $1.1B | +1.0% |
| 2015 | $1.1B | +3.1% |
| 2014 | $1.1B | −5.9% |
| 2013 | $1.1B | −36.2% |
| 2012 | $1.8B | +20.4% |
| 2011 | $1.5B | +46.9% |
| 2010 | $1.0B | −6.8% |
| 2009 | $1.1B | −15.4% |
| 2008 | $1.3B | −22.2% |
| 2007 | $1.7B | — |